Sensible Biotechnologies
Sensible Biotechnologies is a biotechnology company that develops cell-based technologies for the design of mRNA therapeutics.
$47M Series A ·
Led by Oxford Science Enterprises · Source: firstwordpharma.com
Total raised: $51.2M across 2 sourced rounds
All 3 rounds ↓Signals
Sensible Biotechnologies | 605 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
- Series A · $47M
OOxford Science Enterprises (lead),
CChristoph Huber,
CCivilization Ventures,
IIQT,
IIsomer Capital,
KKAYA,
OOTB Ventures,
RRecode Health Ventures,
TTimothy Garnett,
YY Combinator
Source: firstwordpharma.com - Pre Seed · $4.2M
BBlueYard Capital (lead),
CCivilization Ventures, FFlorian Schuster, JJason Foster,
KKAYA,
PPossible Ventures,
RRecode Health Ventures,
SSpringboard Health Angels,
YY Combinator,
ZZAKA VC
Source: genomeweb.com - X account created
- Website created
- Summer 2021
YY Combinator · batch
Source: ycombinator.com
Founders and team
MG
Miroslav Gasparek CEO and Co-FounderLinkedIn · source: foundertrace.comMK
Marian Kupculak Founder
Investors
BBACKED VC
BBlueYard Capitallead investor
CChristoph Huber
CCivilization Ventures
EEuropean Union
- FFlorian Schuster
GGovernment of Slovenia
IIQT
IIsomer Capital
- JJason Foster
KKAYA
OOTB Ventures
OOxford Science Enterpriseslead investor
PPossible Ventures
RRecode Health Ventures
SSpringboard Health Angels
TTimothy Garnett
YY Combinatoraccelerator
ZZAKA VC
Companies like Sensible Biotechnologies
SSingleron Biotechnologies$100M Series B+ · Nov 2021
SScarlet Therapeutics$4.35M Seed · May 2026
CCellivateAAllerGene AI TherapeuticsSeed · Jun 2026
RReCode TherapeuticsSeries B+ · Oct 2023RRidge Biotechnologies$38M Seed · Sep 2026
Other companies backed by Oxford Science Enterprises
OOyster Therapeutics$60M Series A · Nov 2026
AAlethio Therapeutics$90M Series A · Nov 2026
FFluoRok$29.9M Series A · Nov 2026
QQuantrolOx$13.45M Series A · Oct 2026
OOMass Therapeutics$310M Series B+ · Oct 2026
SSalience Labs$125M Series B+ · Oct 2026
Oxford Science Enterprises portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/sensible-biotechnologies (get a free API key).